Invesco ETF holds significant shares of both Abbott Laboratories and AbbVie.
3 reports, 1 independent
Updated Aug 28
Gone quiet
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Invesco ETF holds significant shares of both Abbott Laboratories and AbbVie.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Invesco
US investment management company
-
Abbott Laboratories
American global health care and medical device products company
-
AbbVie
pharmaceutical company
Related events
- Invesco manages the Invesco S&P SmallCap Financials ETF, which tracks US financial service companies.
- Invesco is managing the Invesco S&P 500 Pure Growth ETF.
- Invesco manages the Invesco Dow Jones Industrial Average Dividend ETF.
- Matthew Hamilton acquired shares of an Invesco ETF on October 22, 2026.
- Invesco ETF holds significant positions in companies including Boeing, Palantir, and GE Aerospace.